Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Although the cyanobacteria/BMAA hypothesis of the cause of ALS and other age-related neurodegenerative diseases remains to be proven, it is not too early to ask whether treatment would be possible if the hypothesis were correct. This paper reviews the possible ways that chronic BMAA neurotoxicity could be prevented or treated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In neurological disease and aging, modified proteins are the histopathological hallmarks of a number of diseases, such as SOD1 in amyotrophic lateral sclerosis (ALS) 56,57 , and a class of diseases long referred to as the proteinopathies 57 , including tauopathies in Alzheimer's disease 58 and inclusions of amyloidβ 59 , α -synuclein in Parkinson's 60,61 and multiple secondary ubiquitinopathies”
From How many human proteoforms are there? (2018) · cites this paper as [56]
Citations
Cites
Cox, P. A., Banack, S. A., & Murch, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2235808100 · Cited by 633
Ohtsuki, S., & Terasaki, T. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9374-5 · Cited by 454
Structure of the Blood–Brain Barrier and Its Role in the Transport of Amino Acids
Hawkins, R. A., O’Kane, R. L., Simpson, I. A., & Viña, J. R. (2006) · The Journal of Nutrition · doi:10.1093/jn/136.1.218s · Cited by 453
Murch, S. J., Cox, P. A., & Banack, S. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404926101 · Cited by 416
Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam
Murch, S. J., Cox, P. A., Banack, S. A., Steele, J. C., & Sacks, O. W. (2004) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.2004.00320.x · Cited by 346
Brewer, G. J., Terry, C. A., Aisen, A. M., & Hill, G. M. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520170020016 · Cited by 335
Cycad neurotoxins, consumption of flying foxes, and ALS-PDC disease in Guam
Cox, P. A., & Sacks, O. W. (2002) · Neurology · doi:10.1212/wnl.58.6.956 · Cited by 329
Abnormal glutamate metabolism in amyotrophic lateral sclerosis
Plaitakis, A., & Caroscio, J. T. (1987) · Annals of Neurology · doi:10.1002/ana.410220503 · Cited by 305
Blood-Brain Barrier Carrier-Mediated Transport and Brain Metabolism of Amino Acids
Pardridge, W. M. (1998) · Neurochemical Research · doi:10.1023/a:1022482604276 · Cited by 281
The Biological Effects and Mode of Action of L-Canavanine, a Structural Analogue of L-Arginine
Rosenthal, G. A. (1977) · The Quarterly Review of Biology · doi:10.1086/409853 · Cited by 271
Research works printed but not linked: 7
- Banack SA, 2007, Mar Drugs, 5, 180, 10.3390/md504180 · doi:10.3390/md504180 · Paper page
- Banak SA, 2009, Island Bats: Ecology Evolution, and Conservation
- Mash D, 2008, Neurology, 70, 329
- Pablo J, 2009, Acta Neurol Scand
- Allede CC, 1964, J Biochem Chem, 1102
- Liu X, 2009, Experimental Neurol
- Zhou X, 2008, Neurology, 70, 33
Cited by
How many human proteoforms are there?
Aebersold, R., Agar, J. N., Amster, I. J., Baker, M. S., Bertozzi, C. R., Boja, E. S., Costello, C. E., Cravatt, B. F., Fenselau, C., Garcia, B. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2576 · Cited by 907
Glover, W. B., Mash, D. C., & Murch, S. J. (2014) · Amino Acids · doi:10.1007/s00726-014-1812-1 · Cited by 108
Gene–environment interactions in Parkinson's disease and other forms of parkinsonism
Vance, J. M., Ali, S. F., Bradley, W. G., Singer, C., & Monte, D. A. D. (2010) · NeuroToxicology · doi:10.1016/j.neuro.2010.04.007 · Cited by 80
Self-citationCytotoxic Effects of Environmental Toxins on Human Glial Cells
D‘Mello, F., Braidy, N., Marçal, H., Guillemin, G. J., Rossi, F., Chinian, M., Laurent, D., Teo, C., & Neilan, B. A. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9678-5 · Cited by 39
Metcalf, J. S., Lobner, D., Banack, S. A., Cox, G. A., Nunn, P. B., Wyatt, P. B., & Cox, P. A. (2017) · Amino Acids · doi:10.1007/s00726-017-2445-y · Cited by 38
Metadata
- Authors
- Bradley, W. G.
- Affiliations
- University of Miami (US)
- Corresponding author
- Bradley, Walter G.
- ORCID
- Bradley, Walter G.
- Venue
- Amyotrophic Lateral Sclerosis
- Publisher
- Informa UK Limited
- Published
- 2009-01
- Volume
- 10
- Issue
- sup2
- Pages
- 118-123
- ISSN
- 1471-180X (ISSN-L)
- 1748-2968
- OpenAlex
- W2061575355
- Cited by
- 5
- References
- 45
- Citations by year
- 2018: 1 · 2017: 1 · 2016: 1 · 2014: 1
- FWCI
- 0.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Amyotrophic Lateral Sclerosis (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Physical Sciences › Environmental Science › Environmental Chemistry › Marine Toxins and Detection Methods
- Keywords
- BMAA, cyanobacteria, neurodegenerative diseases, ALS treatment, cyanotoxins
- MeSH terms
- Cyanobacteria, Amino Acids, Amino Acids, Diamino, Amino Acids, Dicarboxylic, Amino Acyl-tRNA Synthetases, Amyotrophic Lateral Sclerosis, Enzyme Inhibitors, Hair, Humans, Neurotoxins, Protein Transport
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis. https://app.cochat.ai/papers/10.3109/17482960903285951
- The paper
- Bradley, W. G. (2009). Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis. Amyotrophic Lateral Sclerosis. https://doi.org/10.3109/17482960903285951
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.